Webinar Series


Cerus offers educational webinars on topics of relevance to the field of pathogen inactivation. The webinars will feature key thought leaders in transfusion medicine and share specific real world examples of how the INTERCEPT Blood System has been successfully implemented into blood centers, resulting in more efficient inventory management and in safer blood components.

For more video-based education, please visit the Symposium Webcasts page.

Webinars
 

Language Event Broadcast
Language:
English

eu flag

RBC and Immune Response

  • George Garratty, PhD, FRCPath
    American Red Cross Blood Services
    Southern California Region
View Webinar arrow
Language:
English

eu flag

Active Hemovigilance Results for INTERCEPT - Review of Multi-Year Studies Presented at International Hemovigilance Seminar (IHS)

  • William F. Reed, M.D.
    Cerus Corporation
    Concord, California, USA
View Webinar arrow
Language:
English

eu flag

Current Status of RBC Component Viability Requirements

  • Larry J. Dumont, PhD
    Dartmouth-Hitchocock Medical Center
    Lebanon, New Hampshire, USA
  • Jose A. Cancelas-Perez, MD
    Hoxworth Blood Center
    Cincinnatti, Ohio, USA
View Webinar arrow
Language:
English

eu flag

Clinical Trials in Transfusion Medicine

  • Dr. Jeffrey McCullough
    University of Minnesota
    Minneapolis, Minnesota
  • Ms. Nancy Heddle
    McMaster University & Canadian Blood Services
    Hamilton, ON, Canada
November 11, 2009
108 minutes

View Webinarred arrow
Lengua: Español

spanishflag

La seguridad de la Sangre en España en la Era de la Inactivación de Patógenos--España como pionera en iniciativas de seguridad de la sangre

  • Dr. Miguel Lozano
    Hospital Clinic Barcelona
    Barcelona, España
  • Dra. Emma Castro
    Centro de Transfusión de Cruz Roja Española
    Madrid, España

4 de nov 2009
55 minutes

View Webinarred arrow

Language:
German


flag
 
Vorteile von INTERCEPT Plasma im Vergleich zu Quarantäne Plasma (Operational Benefits of INTERCEPT Plasma versus Quarantine Plasma)
  • Dr. med. Markus M. Müller
    DRK-Blutspendedienst, Baden-Wuerttemberg-Hessen
    Frankfurt am Main
  • Dr. Johannes Irsch
    Cerus B.V. Amersfoort, Niederlan

Sep 22, 2009
56 minutes

View Webinar
red arrow

Language:
English


eu flag

Role of Pathogen Inactivation in Preparedness for Pandemic H1N1 and Emerging Pathogens

  • Dr. Richard Benjamin
    American Red Cross

    Washington DC, USA
  • Dr. Carl Hanson
    California Department of Public Health
    California, USA

Sep 9, 2009
58 minutes

View Webinar
red arrow

Language:
English

eu flag

The INTERCEPT Blood System in Routine Use:
3 and 5-Year Experiences

  • Dr. Jean-Pierre Cazenave
    EFS-Alsace
    Strasbourg, France
  • Dr. Jean-Claude Osselaer
    Cliniques Universitaires de Mont-Godinne, Universite Catholique de Louvain, Yvoir, Belgium

Oct 20, 2009
62 minutes
 

View Webinar
red arrow

Untitled Document